SGC-CBP30 |
Antagonist of EP300, CREBBP
Probe Summary
More...
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| EP300 |
| |
| CREBBP |
|
100 nM - 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
DSF binding assay
Selectivity Assessment Description:
In DSF binding assays with 45 bromodomains, SGC-CBP30 had no significant activity except against BRD ...
Potency Cellular
In Vitro
EP300
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1073/pnas.1501956112
CREBBP
Mode of Action: Antagonist
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1073/pnas.1501956112
Negative Control Compounds
SGC-CBP30N (BDOIA513)
Notes: SGC-CBP30N (BDOIA513) is the negative control for SGC-CBP30. This compound has moderate activity for CREBBP (Thermal shift 2°C compared to 9.7°C for SGC-CBP30). This compound is inactive against BRD4 (Thermal shift 0.4°C compared to 1.8°C for SGC-CBP30)
Chemical Information
| Molecular Formula | C28H33ClN4O3 |
| SMILEs | COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccc3n2C[C@H](C)N2CCOCC2)cc1Cl |
| InChI | InChI=1S/C28H33ClN4O3/c1-18(32-11-13-35-14-12-32)17-33-25-8-7-22(28-19(2)31-36-20(28)3)16-24(25)30-27(33)10-6-21-5-9-26(34-4)23(29)15-21/h5,7-9,15-16,18H,6,10-14,17H2,1-4H3/t18-/m0/s1 |
| Molecular weight | 508.22 Da |
| AlogP | 5.476040000000006 |
| HBond acceptors | 7 |
| HBond donors | -- |
| Atoms | 69 |
References
Publications
Cross References
ChEMBL: CHEMBL3622373 BindingDB: 188519 PDB: 2LO PubChem: 72201027 canSAR: CANSAR767103 SGCVendors
- Cayman (1613695-14-9)
- MedChem Express (1613695-14-9)
- Sellek
- MCULE
- MilliporeSigma (SGCCBP30)
- Tocris (SGCCBP30)
Note: This is not an exhaustive list and does not indicate endorsement by the Portal.
